Prevalence of long COVID complaints in persons with and without COVID-19.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 04 2023
13 04 2023
Historique:
received:
23
05
2022
accepted:
30
03
2023
medline:
17
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
We studied the prevalence and patterns of typical long COVID complaints in ~ 2.3 million individuals aged 18-70 years with and without confirmed COVID-19 in a Nation-wide population-based prospective cohort study in Norway. Our main outcome measures were the period prevalence of single-occurring or different combinations of complaints based on medical records: (1) Pulmonary (dyspnea and/or cough), (2) Neurological (concentration problems, memory loss), and/or (3) General complaints (fatigue). In persons testing positive (n = 75 979), 64 (95% confidence interval: 54 to 73) and 122 (111 to 113) more persons per 10 000 persons had pulmonary complaints 5-6 months after the test compared to 10 000 persons testing negative (n = 1 167 582) or untested (n = 1 084 578), respectively. The corresponding difference in prevalence of general complaints (fatigue) was 181 (168 to 195) and 224 (211 to 238) per 10 000, and of neurological complaints 5 (2 to 8) and 9 (6-13) per 10 000. Overlap between complaints was rare. Long COVID complaints were only slightly more prevalent in persons with than without confirmed COVID-19. Still, long COVID may pose a substantial burden to healthcare systems in the future given the lasting high incidence of symptomatic COVID-19 in both vaccinated and unvaccinated individuals.
Identifiants
pubmed: 37055494
doi: 10.1038/s41598-023-32636-y
pii: 10.1038/s41598-023-32636-y
pmc: PMC10100609
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6074Informations de copyright
© 2023. The Author(s).
Références
Osteoarthritis Cartilage. 2018 Nov;26(11):1447-1452
pubmed: 30041054
BMJ. 2022 Jan 17;376:e066809
pubmed: 35039315
Lancet Infect Dis. 2021 Oct;21(10):1373-1382
pubmed: 33984263
Eur J Epidemiol. 2022 May;37(5):539-548
pubmed: 35211871
Int Forum Allergy Rhinol. 2021 Dec;11(12):1685-1688
pubmed: 34109765
Nat Commun. 2022 Nov 30;13(1):7363
pubmed: 36450749
PLoS One. 2021 Oct 8;16(10):e0257926
pubmed: 34624023
Tidsskr Nor Laegeforen. 2019 Oct 14;139(15):
pubmed: 31642635
BMJ. 2021 Dec 29;375:e065834
pubmed: 34965929
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
Int J Epidemiol. 2021 Nov 10;50(5):1745-1747
pubmed: 34458903